COFCO Biotechnology shareholders approve director appointment at EGM

COFCO Biotechnology held its fourth extraordinary general meeting of shareholders for 2025 on September 8, 2025. The meeting, which included both an in-person session in Beijing and online voting, saw 509 shareholders participate, representing 1,062,488,689 shares or 57.2325% of the company's total voting shares. The primary agenda was the election of a non-independent director to the ninth board of directors.

Shareholders approved the "Proposal on the Election of a Non-Independent Director to the Ninth Board of Directors" with 1,060,778,787 votes in favor, accounting for 99.8391% of the valid votes. There were 1,333,102 votes against (0.1255%) and 376,800 abstentions (0.0355%). Small and medium investors also largely supported the proposal, with 93.7264% of their votes cast in favor.

The meeting procedures and resolutions were verified by a legal firm, confirming compliance with relevant laws, regulations, and the company's articles of association.